Frederick Kavanagh

1.8k total citations · 1 hit paper
28 papers, 599 citations indexed

About

Frederick Kavanagh is a scholar working on Clinical Biochemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, Frederick Kavanagh has authored 28 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Clinical Biochemistry, 7 papers in Pharmacology and 6 papers in Molecular Biology. Recurrent topics in Frederick Kavanagh's work include Bacterial Identification and Susceptibility Testing (9 papers), Clinical Laboratory Practices and Quality Control (5 papers) and Biosimilars and Bioanalytical Methods (3 papers). Frederick Kavanagh is often cited by papers focused on Bacterial Identification and Susceptibility Testing (9 papers), Clinical Laboratory Practices and Quality Control (5 papers) and Biosimilars and Bioanalytical Methods (3 papers). Frederick Kavanagh collaborates with scholars based in United States. Frederick Kavanagh's co-authors include Annette Hervey, William J. Rôbbins, Frank H. Johnson, Richard H. Goodwin, Gene M. Wild and Mary S. Willis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Agricultural and Food Chemistry and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

Frederick Kavanagh

27 papers receiving 546 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antibiotic Substances From Basidiomycetes

1951 278 citations Frederick Kavanagh, Annette Hervey et al. Proceedings of the National Academy of Sciences profile →

Peers

Frederick Kavanagh

SA

MB

OC

PHARM

IMMUN

Yolanda Repetto Chile

James V. Pivnichny United States

Michael O. Eze Nigeria

CHAO-MIN LIU Switzerland

Shinji Miyadoh Japan

Geewananda P. Gunawardana United States

Moisés Agosı́n United States

Giancarlo Lancini Italy

S. Armstrong Hewitt United Kingdom

Thuioshi Ioneda Brazil

Yolanda Repetto Chile

Frederick Kavanagh

50 ×0.2

SA

305 ×2.4

MB

375 ×2.9

OC

25 ×0.2

PHARM

48 ×0.5

IMMUN

Citations per year, relative to Frederick Kavanagh Frederick Kavanagh (= 1×) peers Yolanda Repetto

Countries citing papers authored by Frederick Kavanagh

Since Specialization

Citations

This map shows the geographic impact of Frederick Kavanagh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick Kavanagh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick Kavanagh more than expected).

Fields of papers citing papers by Frederick Kavanagh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick Kavanagh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick Kavanagh. The network helps show where Frederick Kavanagh may publish in the future.

Co-authorship network of co-authors of Frederick Kavanagh

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick Kavanagh. A scholar is included among the top collaborators of Frederick Kavanagh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick Kavanagh. Frederick Kavanagh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Kavanagh, Frederick. (1989). Wiley Award address. Theory and practice of microbiological assaying for antibiotics.. PubMed. 72(1). 6–10. 1 indexed citations

2.

Kavanagh, Frederick, et al.. (1983). Nonteaching of Evolution?. BioScience. 33(4). 236–236.

3.

Kavanagh, Frederick. (1977). Microbiological Turbidimetric Methods: Linearization of Antibiotic and Vitamin Standard Curves. Journal of Pharmaceutical Sciences. 66(11). 1520–1525. 3 indexed citations

4.

Kavanagh, Frederick. (1975). [4] Antibiotic assays—principles and precautions. Methods in enzymology on CD-ROM/Methods in enzymology. 43. 55–69. 14 indexed citations

5.

Kavanagh, Frederick. (1975). Automated System for Analytical Microbiology V: Calibration Lines for Antibiotics. Journal of Pharmaceutical Sciences. 64(5). 844–850. 2 indexed citations

6.

Kavanagh, Frederick. (1975). Microbiological Diffusion Assay II: Design and Applications. Journal of Pharmaceutical Sciences. 64(7). 1224–1229. 8 indexed citations

7.

Kavanagh, Frederick. (1974). Automated System for Analytical Microbiology IV: Accuracy of Measurements. Journal of Pharmaceutical Sciences. 63(9). 1463–1467. 2 indexed citations

8.

Kavanagh, Frederick. (1971). Automated System for Analytical Microbiology III: Computer Interpolation of Potency. Journal of Pharmaceutical Sciences. 60(12). 1858–1861. 6 indexed citations

9.

Kavanagh, Frederick, et al.. (1971). Automated System for Analytical Microbiology I: Theory and Design Considerations. Journal of Pharmaceutical Sciences. 60(5). 764–767. 9 indexed citations

10.

Kavanagh, Frederick. (1968). Turbidimetric Assays: the Antibiotic Dose-Response Line. Applied Microbiology. 16(5). 777–780. 6 indexed citations

11.

Kavanagh, Frederick. (1968). Turbidimetric Assays: the Antibiotic Dose-Response Line. Applied Microbiology. 16(5). 777–780. 6 indexed citations

12.

Kavanagh, Frederick. (1960). A Commentary on Microbiological Assaying. Advances in applied microbiology. 2. 65–93. 10 indexed citations

13.

Kavanagh, Frederick, et al.. (1959). the economics of <italic>HIGH-OCTANE GASOLINES</italic>. SAE technical papers on CD-ROM/SAE technical paper series. 1. 5 indexed citations

14.

Kavanagh, Frederick, et al.. (1958). Antibiotics Formed by Species of Emericellopsis. Mycologia. 50(3). 370–372. 5 indexed citations

15.

Kavanagh, Frederick, et al.. (1958). d-Methionine and the biosynthesis of cephalosporin N. Archives of Biochemistry and Biophysics. 77(2). 268–274. 19 indexed citations

16.

Kavanagh, Frederick, et al.. (1958). Antibiotics Formed by Species of Emericellopsis. Mycologia. 50(3). 370–370. 4 indexed citations

17.

Kavanagh, Frederick, et al.. (1958). Gibberellins Assay, Fluorometric Determination of Gibberellic and Gibberellenic Acids in Fermentation Products, Commercial Formulations, and Purified Materials. Journal of Agricultural and Food Chemistry. 6(6). 459–463. 23 indexed citations

18.

Goodwin, Richard H. & Frederick Kavanagh. (1952). The fluorescence of coumarin derivatives as a function of pH. II. Archives of Biochemistry and Biophysics. 36(2). 442–455. 19 indexed citations

19.

Kavanagh, Frederick, Annette Hervey, & William J. Rôbbins. (1952). Antibiotic Substances from Basidiomycetes. Proceedings of the National Academy of Sciences. 38(7). 555–560. 69 indexed citations

20.

Kavanagh, Frederick, Annette Hervey, & William J. Rôbbins. (1951). Antibiotic Substances From Basidiomycetes. Proceedings of the National Academy of Sciences. 37(9). 570–574. 278 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact